Fluoroquinolone Toxicity Study

Fluoroquinolone Toxicity Study With these study conclusions, evaluation of preventative and restorative treatment will be explored.

Fluoroquinolone Toxicity Study is a nonprofit 501(c)(3) organization dedicated to driving collaborative research at the cellular & molecular level, aimed to identify the mechanism of damage that can be induced by the fluoroquinolone class of antibiotics. Our mission is to perform research at the cellular and molecular level in collaboration with scientists to determine the mechanism of damage caused by Fluoroquinolones.

Fluoroquinolones and Visual Disturbances: Blurred Vision, Double Vision, and a Possible Link to Eye MusclesAuthor: Jerzy...
08/28/2026

Fluoroquinolones and Visual Disturbances: Blurred Vision, Double Vision, and a Possible Link to Eye Muscles
Author: Jerzy Tyszkowski

Fluoroquinolones, including ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin, are a group of antibiotics used for selected bacterial infections. For years, they have been known to carry a potential risk of serious adverse effects involving tendons, muscles, joints, and the nervous system. Less widely recognized, but described in the medical literature, are visual disturbances, including blurred vision, reduced visual acuity, and double vision, known as diplopia [1-4].

An association between eye-related symptoms and fluoroquinolone use does not mean that every person taking one of these medications will experience visual problems. It does mean, however, that new eye symptoms, particularly those occurring during treatment or shortly afterward, deserve clinical attention and should not automatically be dismissed.

🟢Blurred and Unclear Vision

Patients describe visual disturbances in different ways. Some report blurred vision, difficulty focusing, reduced image clarity, increased light sensitivity, a sensation of “fog” in front of the eyes, or diminished contrast. Product safety information for certain fluoroquinolones has listed adverse events such as visual disturbances, blurred vision, and decreased visual acuity [2-4].
These symptoms do not have a single, simple mechanism. They may be temporary, but they may also require evaluation for ophthalmic, neurologic, vascular, or metabolic causes.
Blurred vision can be associated with ocular-surface problems, changes in the cornea or lens, accommodation difficulties, optic-nerve disorders, intracranial-pressure abnormalities, retinal disease, or effects on the nervous system.

For this reason, cases of blurred vision should not all be attributed solely to an antibiotic. At the same time, a clinician evaluating a patient should be aware of a history of fluoroquinolone exposure, as it may be an important part of the overall clinical picture.

🟢Double Vision: A Symptom Requiring Attention

Diplopia, or double vision, is the perception of two images of a single object. If the double image disappears when either eye is covered, the condition is most often binocular diplopia. This form generally suggests a problem with the proper coordination of the two eyes.

For a person to see a single, clear image, the extraocular muscles must move the eyes in precisely coordinated ways. If one muscle is weakened, painful, restricted, or otherwise dysfunctional, the visual axes may no longer remain properly aligned. The brain then receives two images that do not fully overlap.

A study published in Ophthalmology described 171 spontaneously reported cases of diplopia temporally associated with fluoroquinolone use. The median time from starting treatment to the onset of double vision was 9.6 days, although symptoms were reported both very early and later after treatment began. In some cases, tendon-related problems were reported at the same time [1]. The authors proposed that inflammation or dysfunction of tendon-related structures associated with the extraocular muscles could be a possible mechanism. This hypothesis is biologically plausible in light of the well-documented risk of fluoroquinolone-associated tendinopathy. However, it does not mean that this mechanism has been conclusively demonstrated in every reported case [1].

🟢Can Fluoroquinolones Affect Eye Muscles?

Fluoroquinolones are particularly well known for the risk of tendinitis and tendon rupture, most commonly involving the Achilles tendon. However, adverse effects can also involve other musculoskeletal structures. Drug regulators, including the United Kingdom’s Medicines and Healthcare products Regulatory Agency, warn that systemic fluoroquinolones can cause serious, sometimes long-lasting or potentially irreversible adverse effects involving tendons, muscles, joints, the nervous system, and the senses [5].
In relation to the ocular motor system, several terms should be distinguished. The extraocular muscles are not “eye ligaments.” They are muscles that move the eyeball and attach to the eye through tendon-related structures. In principle, impairment of muscle function, its nerve supply, or the associated tendon structures may lead to ocular misalignment and binocular diplopia.

Current evidence does not allow a conclusion that fluoroquinolones routinely cause permanent injury to eye-muscle attachments or “weakening of eye ligaments.” The most scientifically accurate wording is that reports and case descriptions suggest a possible association between fluoroquinolones and diplopia. One proposed mechanism is tendinopathy involving structures associated with the extraocular muscles [1,6].

🟢Other Possible Eye Problems

Visual disturbances occurring during or after fluoroquinolone treatment may take different forms. Problems reported or listed in drug-safety documentation include:

• Blurred, unclear, or “wavering” vision
• Reduced visual acuity
• Double vision, particularly binocular diplopia
• Eye pain or pain with eye movements
• Photophobia or increased sensitivity to light
• Disturbances in color perception, flashes, or visual spots
• Headache accompanied by visual disturbances
• Rare reports involving the optic nerve or other eye structures [2-4,7,8]

Each of these symptoms can have many potential causes. For example, double vision may be associated with thyroid disease, diabetes, myasthenia gravis, cranial-nerve disorders, stroke, orbital disease, migraine, trauma, or the effects of other medications. Similarly, sudden loss of visual clarity requires ophthalmologic assessment because it may be a sign of retinal, optic-nerve, or vascular disease requiring prompt treatment.

🟢When Urgent Care Is Needed

New or worsening visual disturbances should be taken seriously, particularly if they occur during fluoroquinolone treatment or soon after therapy has ended. Urgent medical evaluation is especially important in the following situations:

✔ Sudden double vision
✔ Rapid deterioration in visual acuity
✔ Loss of part of the visual field, a “curtain,” or a dark spot in the vision
✔ Flashes of light, numerous new floaters, or a sensation that the visual image is detaching
✔ Eye pain, eye redness, or severe pain with eye movements
✔ Drooping eyelid, unequal pupils, or restricted eye movement
✔ Severe headache accompanied by visual symptoms
✔ Limb weakness, speech difficulty, facial drooping, balance problems, or numbness occurring with visual symptoms

These symptoms may indicate a neurologic, vascular, or ophthalmic emergency. They should not be assumed to be only a temporary medication side effect.

🟢The Importance of Reporting Adverse Events

A person who develops a new vision problem while taking a fluoroquinolone should contact the prescribing clinician or an ophthalmologist. When symptoms are acute, emergency services should be contacted as soon as possible. Decisions about continuing, stopping, or changing an antibiotic should be made by a clinician, taking into account the type of infection, available alternatives, and the risk of complications. It is also important to document the medication name, dose, treatment start and end dates, symptom onset, and the results of ophthalmologic and neurologic examinations. Careful reporting of suspected adverse drug reactions helps regulators and researchers better identify rare but potentially serious medication-related complications.

🟢Conclusion

Fluoroquinolones can be valuable for treating selected infections, but their use carries a well-recognized risk of adverse effects involving tendons, muscles, and the nervous system. The medical literature also contains reports and case descriptions linking this class of antibiotics with double vision and other visual disturbances [1,6-8].

The key message is straightforward: following fluoroquinolone exposure, blurred vision, reduced visual acuity, pain with eye movement, or double vision should not be ignored.

These symptoms require professional assessment because they may represent an adverse drug reaction, but they may also signal other conditions requiring rapid diagnosis and treatment.

💊Common medications in the fluoroquinolone class - Cipro/ciprofloxacin, levofloxacin, moxifloxacin; see complete list in all forms for humans and pets: https://fq100.org/drug-list

Find support and resources on our sites:

🌐 Website & Resources: https://fq100.org/
▶️ YouTube: https://www.youtube.com/
🔵 Facebook: https://www.facebook.com/fqtoxicitystudy/
🐦 X: https://x.com/FQ_100

🧿Disclaimer: This article is intended solely for educational and informational purposes. It does not constitute medical advice, diagnosis, or a recommendation to start, continue, modify, or stop treatment. Anyone experiencing visual disturbances, eye pain, double vision, or other concerning symptoms should consult a physician or ophthalmologist. In the event of sudden visual deterioration, double vision accompanied by neurologic symptoms, or severe eye pain, urgent medical care should be sought immediately.
🧿Disclosure: The author used artificial-intelligence tools solely for language editing, text organization, and improvement of readability. The author retains full responsibility for the content, interpretation of sources, and views expressed in this article.

References
1. Fraunfelder FW, Fraunfelder FT. Diplopia and fluoroquinolones. Ophthalmology. 2009;116(9):1814-1817. doi:10.1016/j.ophtha.2009.06.027.
https://pubmed.ncbi.nlm.nih.gov/19643481/
2. U.S. Food and Drug Administration. CIPRO (ciprofloxacin hydrochloride) prescribing information. Revised 2016. The adverse-reaction information includes blurred vision, disturbed vision, decreased visual acuity, and diplopia.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019537s086lbl.pdf
3. U.S. Food and Drug Administration. LEVAQUIN (levofloxacin) prescribing information. Revised 2019. Postmarketing eye disorders include vision disturbance, diplopia, reduced visual acuity, blurred vision, and scotoma.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020634s072lbl.pdf
4. U.S. Food and Drug Administration. AVELOX (moxifloxacin hydrochloride) prescribing information. Revised 2020. The adverse-reaction information includes blurred vision and postmarketing reports of vision loss.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021277Orig1s062,021085Orig1s066lbl.pdf
5. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update. August 30, 2023.
https://www.gov.uk/drug-safety-update/fluoroquinolone-antibiotics-reminder-of-the-risk-of-disabling-and-potentially-long-lasting-or-irreversible-side-effects
6. Touray M, Ando V, Samutelela E, Zuber J-P. Binocular diplopia: a possible adverse effect of fluoroquinolone therapy. Case Reports in Ophthalmological Medicine. 2020;2020:8843182. doi:10.1155/2020/8843182.
https://pubmed.ncbi.nlm.nih.gov/33299626/
7. Vrabec TR, Sergott RC, Jaeger EA, Savino PJ, Bosley TM. Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride. Ophthalmology. 1990;97(6):707-710. doi:10.1016/S0161-6420(90)32518-6.
https://pubmed.ncbi.nlm.nih.gov/2374675/
8. Samarakoon N, Harrisberg B, Ell J. Ciprofloxacin-induced toxic optic neuropathy. Clinical & Experimental Ophthalmology. 2007;35(1):102-104. doi:10.1111/j.1442-9071.2007.01427.x.
https://pubmed.ncbi.nlm.nih.gov/17300586/

Summer Heat Is Brutal When Living With FQADTired of the heat?  Like me, some people living with fluoroquinolone-associat...
08/22/2026

Summer Heat Is Brutal When Living With FQAD

Tired of the heat? Like me, some people living with fluoroquinolone-associated disability (FQAD)* find summer heat much more than uncomfortable – it’s brutal. Hot weather, humidity, direct sun, walking in the heat, hot cars, saunas, and hot tubs may trigger a pounding heart rate and a sudden flu-like feeling as the body tries to compensate in its dysfunctional state. What could be happening to us?

The body regulates temperature through a complex network involving the autonomic nervous system, circulation, metabolism, mitochondria, hormones, hydration, electrolytes, and temperature-control centers in the brain. Fluoroquinolone antibiotics have been associated in scientific literature with mitochondrial dysfunction, oxidative stress, and nervous system adverse effects.[1-3] A 2025 study examining ciprofloxacin and levofloxacin in human cells found prominent dysfunction involving complexes I and IV of the mitochondrial electron transport chain and identified specific mitochondrial proteins affected by these drugs.[3] Because mitochondria and the autonomic nervous system both play important roles in the body’s response to heat, these effects may help explain why many of us have difficulty tolerating high temperatures or recovering after becoming overheated.

Mitochondria do much more than simply “make energy.” They continually produce ATP - the energy needed to support the heart and skeletal muscles, maintain circulation, regulate cellular calcium, operate cellular ion pumps, support nerve signaling, and help cells respond to physical stress. During heat exposure, heart rate rises, more blood is directed toward the skin, sweating increases, and the cardiovascular and nervous systems must continually adjust blood pressure and circulation to maintain a safe internal temperature.[4,5]

All of these processes require energy. If mitochondrial energy production is impaired, the body may have less reserve available to meet the additional demands of heat. This could help explain why a temperature that is manageable for one person may cause disproportionate problems for someone with FQAD.

Heat can also affect mitochondria directly. Experimental research indicates that significant heat stress can increase mitochondrial production of reactive oxygen species, reduce mitochondrial membrane potential, interfere with oxidative phosphorylation and ATP production, and disrupt calcium balance within cells.[6,7]

Mitochondria help regulate cellular calcium but are also vulnerable to calcium overload. Mitochondrial dysfunction and abnormal calcium handling may therefore reinforce one another, potentially affecting muscles, nerves, blood vessels, and cellular energy production. In my own experience, even wearing a hat in direct sun can trigger a migraine that lasts one to two days. I cannot say precisely which mechanism is responsible, but trapped heat, direct sun, slight pressure around my head, and the increased demands placed on temperature regulation appear to create a particularly bad combination.

Cells normally respond to heat by activating heat-shock proteins, which help stabilize or refold damaged proteins and assist cells in surviving temporary stress. Heat exposure can also influence mitochondrial biogenesis, fusion, fission, and mitophagy - the processes through which cells maintain, replace, reorganize, or remove mitochondria.[7] If these protective and quality-control systems are already strained, recovery after overheating may be more difficult. This was apparent when I experienced the potential severity of this firsthand while spending a week out of town in an uncomfortable 80-degree environment that I could neither control nor leave. My heart rate rose into an aerobic-exercise range and remained elevated, even with little activity. It took me approximately three months to recover from the resulting physical crash, which felt like having the flu (minus the stomach issues), new tinnitus, fatigue, speech and cognitive problems.

🌀 The lesson: It is important to distinguish between controlled, tolerable heat exposure and excessive heat stress. Repeated, carefully controlled heat exposure can produce adaptive responses, but someone who becomes weak, dizzy, tachycardic**, cognitively impaired, or physically unable to function should not try to push through those symptoms.[7]

The autonomic nervous system is another important part of the picture. This system controls sweating, heart rate, blood pressure, and the widening and narrowing of blood vessels without requiring conscious effort. Dysautonomia is a broad term for disorders in which these automatic functions do not regulate normally.[8] As body temperature rises, blood vessels near the skin widen and the heart beats faster to move warm blood toward the skin, while sweating helps release heat through evaporation. At the same time, the body must maintain sufficient blood pressure and blood flow to the brain and other organs.[4,5]

When autonomic regulation is unstable, this cooling response may become exaggerated or inefficient. Heart rate may rise sharply, blood pressure may become unstable, and the body may struggle to maintain circulation while also attempting to release heat. These problems may be particularly noticeable when standing, walking, exercising, or remaining in direct sun. Humidity can make matters worse because perspiration does not evaporate as effectively, meaning that even someone who is sweating heavily may not be cooling efficiently.

Heat also changes where blood is distributed throughout the body. As more blood is directed toward the skin for cooling, less may return to the heart with each beat. The heart may compensate by beating faster to maintain cardiac output and blood flow to the brain and other organs. In someone with low circulating blood volume, impaired vascular regulation, or dysautonomia, this response may become exaggerated. This may help explain why simply standing or walking in the heat can produce a heart rate more typical of aerobic exercise.[4,5]

Heat intolerance can have several contributing factors. Some people with FQAD also live with thyroid dysfunction, heart rhythm disturbances, or autonomic problems, all of which may further impair temperature regulation. Anemia, dehydration, electrolyte imbalances, medication effects, blood sugar problems, and infection should also be considered.

Because heat tolerance can vary so much from one person to another, it may be useful to identify and document one’s threshold:

✔recording the temperature
✔humidity
✔duration of exposure
✔activity level
✔heart rate and blood pressure when available
✔symptoms
✔recovery time
.........may reveal patterns that are otherwise difficult to recognize. This information may also help determine whether mitochondrial energy impairment, an exaggerated autonomic response, a heart rhythm disturbance, or several overlapping factors could be contributing.

For those of us who experience these crashes, summer heat is not merely a huge challenge, it is a significant stressor that needs to be taken seriously. Understanding the potential causes may help us better navigate heat exposure, avoid an unnecessary crash, and prevent the long wait to return to our previous baseline!

💊Common medications in the fluoroquinolone class - Cipro/ciprofloxacin, levofloxacin, moxifloxacin; see complete list in all forms for humans and pets: https://fq100.org/drug-list

*FQAD - FDA definition: https://fq100.org/fda-warnings

** Tachycardic means an abnormal fast heart rate.

Disclaimer: Fluoroquinolone Toxicity Study does not provide medical advice. All videos, articles, posts, and written materials are intended for educational and informational purposes only. We make every reasonable effort to provide accurate information, but this material is not a substitute for professional medical advice, diagnosis, or treatment. Symptoms, underlying medical conditions, treatment responses, and the effects of medications or supplements may vary significantly among individuals.

Use of artificial intelligence: AI-assisted tools were used to help locate scientific sources and to improve the language, organization, and editing of this article. All scientific claims and references were reviewed before inclusion

References

1. U.S. Food and Drug Administration. Cipro IV (ciprofloxacin) Prescribing Information. Revised September 2024.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019847Orig1s064correctedlbl.pdf
2. Michalak K, Sobolewska-Włodarczyk A, Włodarczyk M, Sobolewska J, Woźniak P, Sobolewski B. Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications. Oxidative Medicine and Cellular Longevity. 2017;2017:8023935.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5632915/
3. Reinhardt T, El Harraoui Y, Rothemann A, et al. Chemical Proteomics Reveals Human Off-Targets of Fluoroquinolone Induced Mitochondrial Toxicity. Angewandte Chemie International Edition. 2025;64(18):e202421424.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12036814/
4. Crandall CG, González-Alonso J. Cardiovascular Function in the Heat-Stressed Human. Acta Physiologica. 2010;199(4):407-423.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3496876/
5. Low DA, Keller DM, Wingo JE, Brothers RM, Crandall CG. Sympathetic Nerve Activity and Whole-Body Heat Stress in Humans. Journal of Applied Physiology. 2011;111(5):1329-1334.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3220304/
6. Iba T, Helms J, Nagaoka I, Ferrer R, Levy JH. Heat Stress-Induced Mitochondrial Damage and Its Impact on Leukocyte Function. Journal of Intensive Care. 2025;13:61.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12584344/
7. Keefe MS, Levitt DE, Vellers HL, et al. Mitochondrial Adaptations from Heat Acclimation: A Narrative Review. Journal of Thermal Biology. 2025;133:104283.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12537051/
8. Cleveland Clinic. Dysautonomia: What It Is, Symptoms, Types and Treatment. Last reviewed September 11, 2023.
https://my.clevelandclinic.org/health/diseases/6004-dysautonomia

Do We Always Need the Radiation?  Rethinking Medical Imaging for Patients With FQAD — and for All of UsBy Jerzy Tyszkows...
08/17/2026

Do We Always Need the Radiation? Rethinking Medical Imaging for Patients With FQAD — and for All of Us
By Jerzy Tyszkowski - Fluoroquinolone Toxicity Study NFP

Modern medicine has extraordinary imaging technologies capable of revealing diseases that physicians could not have detected only a few generations ago. Conventional X-rays, computed tomography (CT), mammography, fluoroscopy, nuclear medicine, and positron emission tomography (PET) can be essential and, in many circumstances, lifesaving. Magnetic resonance imaging (MRI) and diagnostic ultrasound offer additional ways of looking inside the human body. Yet an important distinction among these technologies is too often overlooked by patients: conventional X-rays, CT, mammography, fluoroscopy, nuclear medicine, PET, and PET/CT involve ionizing radiation, whereas ultrasound and MRI do not.

♦️Why Ultrasound May Be Useful For FQAD

This distinction deserves particular consideration for patients with Fluoroquinolone-Associated Disability (FQAD), although the underlying principle applies to everyone. The European Medicines Agency has formally warned that fluoroquinolones can produce long-lasting, disabling, and potentially permanent adverse effects involving tendons, muscles, joints, and the nervous system.[1] These effects can include tendon inflammation and rupture, muscle pain and weakness, joint pain and swelling, difficulty walking, and neurological abnormalities.

Many patients with persistent fluoroquinolone-associated problems consequently undergo repeated investigations of the Achilles tendons, shoulders, wrists, hands, fingers, knees, muscles, joints, and peripheral nerves. These are also precisely the kinds of structures that modern high-resolution musculoskeletal ultrasound can often evaluate. Patients sometimes still think of ultrasound primarily as a technology used during pregnancy or for abdominal examinations. Modern musculoskeletal ultrasound is much more than that.
➥ High-frequency ultrasound can visualize:
• tendon thickness and fibrillar architecture
• tendinopathy
• partial and complete tendon tears
• tendon sheaths
• tenosynovitis
• bursae and fluid collections
• selected ligament abnormalities
• muscle structure and injuries
• joint effusions
• synovial abnormalities
• entheses where tendons attach to bone
• superficial masses and cysts
• calcifications
• selected peripheral nerves

Doppler ultrasound can additionally provide information about vascularity associated with certain inflammatory processes. Perhaps most importantly, ultrasound is a dynamic examination. The examiner can watch a tendon move, observe a muscle during contraction, follow a nerve or tendon through movement, compare the symptomatic structure with the opposite side, and place the probe directly over the area where the patient reports pain. The FDA confirms that ultrasound uses high-frequency sound waves, provides real-time imaging, and, unlike X-ray imaging, does not expose the patient to ionizing radiation.[2]

This becomes particularly interesting when clinical practices are compared internationally. Musculoskeletal ultrasound has been integrated into rheumatology and musculoskeletal medicine across numerous European countries, although implementation varies considerably. A European survey involving EULAR member countries found substantial use of musculoskeletal ultrasound, with rheumatology listed among the principal specialties performing it in 64.5% of responding countries. Ultrasound education had also become part of rheumatology training curricula in more than half of the surveyed countries.[3] European professional organizations have developed standardized ultrasound techniques for anatomical regions including the shoulder, wrist, hand, knee, ankle, and Achilles tendon.

A European patient suffering from persistent problems following fluoroquinolone exposure recently described her own experience to us. Her orthopedist initially used ultrasound to examine her shoulders, wrist, fingers, Achilles tendon, and neck muscles. According to her description, conventional radiography was reserved primarily for situations in which a fracture or another bone abnormality was suspected. Her ultrasound examinations demonstrated structural changes, fluid, and inflammatory abnormalities in soft tissues.

One patient’s experience is not scientific evidence and should not be presented as such. However, it raises an important question about diagnostic culture: when the suspected pathology lies primarily in a tendon, muscle, tendon sheath, bursa, or accessible peripheral nerve, should high-quality ultrasound be considered more frequently before proceeding to other forms of imaging?

The Achilles tendon is an obvious example for the FQAD population. Fluoroquinolone-associated tendon injury is well recognized by regulators.[1] If a physician suspects a fracture or significant bone abnormality, conventional radiography may be entirely appropriate. But when the clinical question concerns the tendon itself, ultrasound can evaluate its thickness, architecture, areas of tendinopathy, partial or complete rupture, and surrounding soft tissues. It can also be repeated over time without exposing the patient to ionizing radiation.

The same principle applies to many shoulder abnormalities. A systematic review and meta-analysis involving 23 studies and more than 2,000 shoulders found strong diagnostic performance for ultrasound in rotator-cuff disease when performed by experienced operators. In studies directly comparing ultrasound with MRI, no statistically significant difference was found in sensitivity, specificity, or accuracy for supraspinatus tears.[4] That does not mean that ultrasound replaces MRI. It demonstrates that, for selected clinical questions, a less complex examination can sometimes provide substantial diagnostic information.

MRI remains indispensable. It can visualize bone marrow, deep structures, and many intra-articular abnormalities that ultrasound cannot adequately assess. It is also important to emphasize that MRI does not use ionizing radiation. Therefore, the argument presented here is not “ultrasound instead of MRI,” nor is it “ultrasound instead of every X-ray.” It is more rational than that: use the imaging modality capable of answering the clinical question while avoiding unnecessary exposure, expense, and complexity whenever possible. The reason this deserves renewed attention extends far beyond FQAD. Ionizing radiation is not biologically inert. X-rays and gamma radiation are classified by the International Agency for Research on Cancer as carcinogenic to humans.[5] Ionizing radiation has sufficient energy to ionize biological molecules and can damage DNA.

This does not mean that every diagnostic X-ray causes cancer or that medically indicated radiological examinations should be refused. The diagnostic information obtained from CT, radiography, mammography, PET, and nuclear medicine can save a patient’s life. The radiation itself, however, is not the therapeutic benefit. The benefit comes from the diagnostic information obtained through the exposure. Consequently, when exposure is necessary and justified, its benefit may greatly exceed its potential risk. When an equally appropriate non-ionizing examination can provide the same necessary information, the balance is different.

A major study published in JAMA Internal Medicine in 2025 makes this discussion particularly timely. Smith-Bindman and colleagues estimated that approximately 93 million CT examinations were performed in about 62 million patients in the United States in 2023.[6] Using contemporary CT utilization, organ-dose estimates, and established radiation-risk models, the investigators projected approximately 102,700 future cancers associated with radiation from those examinations. Their analysis estimated that, if current CT utilization and radiation-dose practices persist, CT-associated malignancies could eventually account for approximately 5% of new cancer diagnoses annually in the United States.[6]
These numbers require responsible interpretation. The study did not observe 102,700 people developing cancer and prove that each cancer resulted from CT. It was a population-level lifetime risk projection. Nevertheless, the magnitude of the estimate is difficult to ignore, and the authors themselves emphasized the importance of justifying CT use and optimizing radiation dose.

♦️Why Cumulative Radiation Deserves Consideration

An even more important observation emerged from a very large study of children and adolescents published in the New England Journal of Medicine in 2025. Investigators followed 3,724,623 children and adolescents, encompassing more than 35 million person-years of observation.[7] They examined cumulative radiation exposure to active bone marrow from medical imaging and subsequent hematologic malignancies. Risk increased with increasing cumulative radiation dose. The investigators estimated that 10.1% of hematologic cancers in this specific cohort could be attributable to radiation from medical imaging, with a 95% confidence interval of 5.8% to 14.2%.[7]
This is an extremely important distinction: the finding does not mean that 10–15% of all cancers in the general population are caused by diagnostic imaging. It concerns the estimated attributable fraction of hematologic cancers in this particular pediatric and adolescent cohort. Nevertheless, it reinforces the principle that cumulative medical radiation should not simply be regarded as biologically irrelevant.

♦️Mammography Requires A Balanced Discussion

Mammography presents an especially important and more complicated example. Mammography uses low-dose X-rays and therefore exposes breast tissue to ionizing radiation. Multiple peer-reviewed publications have examined radiation-induced breast-cancer risk associated with repeated mammographic screening.[8–10] Miglioretti and colleagues modeled annual screening of 100,000 women from ages 40 through 74 and projected approximately 125 radiation-induced breast cancers and 16 deaths from those cancers.[8] At the same time, the same analysis projected approximately 968 breast-cancer deaths prevented through screening.

That comparison is essential. The study does not support abandoning mammography. It demonstrates something more sophisticated and scientifically important: a diagnostic procedure can carry a small radiation-associated carcinogenic risk while simultaneously providing a substantially greater population-level benefit through earlier cancer detection.

Other investigators have independently examined radiation-induced breast-cancer risk from mammographic screening.[9] A dedicated review titled Breast Cancer Induced by X-Ray Mammography Screening? examined the issue in the context of low-dose radiobiology.[10] Therefore, it would be inaccurate to describe radiation-associated carcinogenesis from mammography as a subject for which no scientific literature exists. At the same time, it would be equally inaccurate to tell women simply to replace mammography with ultrasound. Breast ultrasound and mammography visualize different pathological features. Mammography can reveal microcalcification patterns associated with ductal carcinoma in situ and early malignancy that ultrasound may not reliably detect. Breast ultrasound and, in selected circumstances, MRI can provide important additional information without ionizing radiation, but the optimal modality depends on age, breast density, family history, genetic susceptibility, symptoms, and previous findings.

The rational question is not, “Should I refuse mammography?” but rather, “Considering my individual risk, is this the appropriate examination, and could ultrasound or MRI provide useful complementary or alternative information in my particular situation?”

♦️Lessons From Patients With Scoliosis

The history of patients with scoliosis provides another important warning about cumulative diagnostic radiation. Historically, children and adolescents with spinal deformities frequently underwent repeated full-spine radiographs during years of growth and clinical surveillance. Long-term follow-up of women repeatedly exposed to diagnostic X-rays for scoliosis and other spinal disorders subsequently identified increased breast-cancer risk and mortality, including evidence linking estimated radiation dose to subsequent breast-cancer risk.[11,12]

A later systematic review and meta-analysis encompassing more than 35,000 scoliosis patients examined cancer and mortality risks associated with repeated radiographic exposure and emphasized the importance of reducing radiation exposure during long-term surveillance when clinically feasible.[13] These patients illustrate a principle that applies far beyond scoliosis: an individually small exposure is not necessarily equivalent to cumulative exposure accumulated over years or decades. A person’s lifetime medical-imaging history can include dental X-rays, chest X-rays, spinal radiographs, mammography, fluoroscopic procedures, emergency CT examinations, repeated CT surveillance, nuclear-medicine studies, and PET examinations. Each may have been individually justified. But cumulative exposure should still matter when clinicians decide whether another ionizing examination is necessary.

♦️PET

PET deserves particular attention because patients may not realize that it also involves ionizing radiation. Unlike conventional radiography, in which radiation originates outside the body, PET requires administration of a radioactive radiotracer. The emitted radiation is then detected to construct functional and metabolic images. PET can provide extraordinarily valuable information in oncology, cardiology, neurology, and other fields, and medically necessary PET should not be discouraged. However, PET is not radiation-free. In PET/CT, exposure can arise from both the radioactive PET tracer and the CT component. The magnitude depends on the tracer, administered activity, patient characteristics, and the CT protocol.
PET/MRI can eliminate the CT component of the exposure because MRI itself does not use ionizing radiation, but PET/MRI still involves radiation from the radioactive tracer. This distinction is important: a lower-radiation examination is not necessarily a zero-ionizing-radiation examination.

♦️ Fluoroscopy & Conventional Nuclear Medicine

Fluoroscopy and conventional nuclear medicine should also be included in this discussion. Fluoroscopy uses X-rays to produce real-time images and can result in substantially different radiation doses depending on procedure type and duration. Nuclear medicine introduces radioactive material into the patient to provide functional information. These technologies have indispensable clinical applications. Their inclusion here is not an argument against their use. It is a reminder that, when discussing a patient’s cumulative medical-radiation exposure, CT is only one part of the picture.

♦️Understanding Low-Dose Radiation Risk/FQAD

The concept that a low dose should not automatically be equated with zero biological interaction is also important. At very low radiation doses, individual cancer risk becomes difficult to measure epidemiologically, and scientific uncertainty increases. It would therefore be excessive to claim that every arbitrarily small dose produces measurable disease in every person. But uncertainty at low doses is not evidence that ionizing radiation becomes biologically beneficial or completely inert. Radiation protection has therefore developed around the principles of justification and optimization: perform an ionizing examination when its expected clinical benefit warrants the exposure, and, when it is necessary, obtain the required diagnostic information with an appropriately optimized dose.

This principle is particularly relevant to people with chronic diseases who may undergo many diagnostic procedures during their lifetimes. Patients with FQAD represent one such population. There is currently no evidence establishing that medically indicated diagnostic radiation uniquely worsens FQAD, and we should not make that claim without data. What we can say is that some patients with FQAD experience multisite tendon, muscle, joint, and neurological symptoms and may therefore undergo repeated imaging. Avoiding unnecessary ionizing radiation in such patients follows the same radiation-protection principles that should apply to everyone.

♦️Future Research

This also creates an important research opportunity. A standardized high-resolution ultrasound protocol could potentially examine Achilles tendons, patellar and quadriceps tendons, rotator-cuff and biceps tendons, wrist and hand tendons, selected muscles, entheses, and selected peripheral nerves in patients with persistent FQAD. Investigators could measure tendon thickness, echotexture, fibrillar organization, focal structural defects, calcification, peritendinous fluid, Doppler vascularity where appropriate, muscle architecture, and nerve cross-sectional area. Symptomatic sites could be compared with contralateral structures, and patients could potentially be followed longitudinally without ionizing radiation.

Such research could begin answering questions that remain largely unexplored. Do patients with persistent FQAD demonstrate reproducible ultrasonographic abnormalities? Are the abnormalities multisite? Can structural abnormalities be demonstrated in tissues that appear relatively normal during routine physical examination? Do findings correlate with pain, weakness, or functional impairment? Are there identifiable patterns of tendon or muscle involvement following fluoroquinolone exposure? Do those abnormalities change during deterioration or recovery? Could high-resolution ultrasound eventually contribute objective imaging biomarkers for particular components of fluoroquinolone-associated musculoskeletal injury? We do not currently have sufficient evidence to answer these questions. That is precisely why systematic research would be valuable.

♦️Ultrasound and Appropriate Use

Patients should not refuse medically necessary imaging. CT, radiography, mammography, and PET can provide essential, sometimes lifesaving information. However, patients may reasonably ask whether ultrasound, MRI, or another non-ionizing method could adequately answer the clinical question. Ultrasound can be particularly useful for accessible tendons, muscles, bursae, ligaments, joint effusions, and peripheral nerves.

Although ultrasound introduces acoustic energy that can produce small thermal or mechanical effects, the FDA reports an excellent safety record and recommends prudent use by trained professionals.[2] Unlike X-ray imaging, ultrasound does not use ionizing radiation. Its effectiveness is highly operator-dependent, and its availability may be influenced by training, equipment, reimbursement, and referral practices. The goal is not to place one technology against another, but to select the most appropriate examination for each patient and clinical question.

♦️The Real Issue is Appropriate Imaging

Ionizing radiation has transformed medicine, but it is also a recognized carcinogenic exposure. The latest research provides additional reasons to take cumulative exposure seriously. A 2025 analysis projected approximately 103,000 future cancers associated with a single year of CT utilization in the United States under its modeling assumptions.[6] A cohort of almost 3.7 million children and adolescents demonstrated increasing hematologic-cancer risk with increasing cumulative radiation from medical imaging and estimated a 10.1% attributable fraction within that specific population.[7] Mammography modeling demonstrates a small projected radiation-induced breast-cancer burden while simultaneously demonstrating substantially greater expected benefits from appropriate screening.[8] Decades of observation of patients repeatedly radiographed for scoliosis provide another reminder that cumulative exposure deserves attention.[11–13]

♦️Conclusion

None of these findings justify abandoning medically necessary imaging. They support a simple principle: use CT, radiography, mammography, PET, or MRI when clinically appropriate—but consider ultrasound when it can adequately answer the same question.

This is particularly relevant to FQAD because tendons, muscles, joints, and nerves are among the structures potentially affected by fluoroquinolone adverse reactions.[1] High-resolution ultrasound may help document structural abnormalities while avoiding ionizing radiation, offering an underexplored diagnostic opportunity for a population in need of objective markers. The goal is not to abandon lifesaving imaging, but to use it intelligently: the right examination for the right patient and clinical question, without unnecessary radiation.

➥For more info on imaging visit our page: https://fq100.org/insights

✅Disclaimer: This article is provided for educational, scientific, and public-awareness purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations and should not be used as a substitute for consultation with a qualified healthcare professional. Nothing in this article is intended to encourage patients to refuse, postpone, or discontinue medically indicated X-rays, CT scans, mammography, fluoroscopy, nuclear medicine, PET/PET-CT, or any other diagnostic procedure. These technologies can be essential and lifesaving when appropriately indicated.

✅Artificial Intelligence Disclosure: ChatGPT was used to assist with research, organization, fact-checking, and editing. The author reviewed all material and remains responsible for the article’s content, interpretations, and conclusions.

Find support and resources on our sites:

🌐 Website & Resources: https://fq100.org/
▶️ YouTube: https://www.youtube.com/
🔵 Facebook: https://www.facebook.com/fqtoxicitystudy/
🐦 X: https://x.com/FQ_100

References
[1] European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. EMA; 2018.
[2] U.S. Food and Drug Administration. Ultrasound Imaging: Benefits/Risks. FDA.
[3] Naredo E, D’Agostino MA, Conaghan PG, et al. Current state of musculoskeletal ultrasound training and implementation in Europe: results of a survey of experts and scientific societies. Rheumatology (Oxford). 2010;49(12):2438–2443. doi:10.1093/rheumatology/keq243.
[4] Farooqi AS, et al. Diagnostic Accuracy of Ultrasonography for Rotator Cuff Tears: A Systematic Review and Meta-analysis. Orthopaedic Journal of Sports Medicine. 2021.
[5] International Agency for Research on Cancer. Ionizing Radiation, Part 1: X- and Gamma-Radiation, and Neutrons. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 75. Lyon: IARC; 2000.
[6] Smith-Bindman R, Chu PW, Azman Firdaus H, et al. Projected Lifetime Cancer Risks From Current Computed Tomography Imaging. JAMA Internal Medicine. 2025;185(6):710–719. doi:10.1001/jamainternmed.2025.0505.
[7] Smith-Bindman R, Alber SA, Kwan ML, et al. Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk. New England Journal of Medicine. 2025;393:1269–1278. doi:10.1056/NEJMoa2502098.
[8] Miglioretti DL, Lange J, van den Broek JJ, et al. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Annals of Internal Medicine. 2016;164(4):205–214. doi:10.7326/M15-1241.
[9] Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology. 2011;258(1):98–105.
[10] Pauwels EKJ, Foray N, Bourguignon MH. Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology. Medical Principles and Practice. 2016;25(2):101–109. doi:10.1159/000442442.
[11] Hoffman DA, Lonstein JE, Morin MM, Visscher W, Harris BS III, Boice JD Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic X-rays. Journal of the National Cancer Institute. 1989.
[12] Ronckers CM, Land CE, Miller JS, Stovall M, Lonstein JE, Doody MM. Cancer mortality among women frequently exposed to radiographic examinations for spinal disorders. Radiation Research. 2010.
[13] Luan FJ, Wan Y, Mak KC, Ma CJ, Wang HQ. Cancer and mortality risks of patients with scoliosis from radiation exposure: a systematic review and meta-analysis. European Spine Journal. 2020.

Address

845 S. Main Street, Ste. 102
Lombard, IL
60148

Alerts

Be the first to know and let us send you an email when Fluoroquinolone Toxicity Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Fluoroquinolone Toxicity Study:

Shortcuts

Share